Purchase Order 36C24625P1583

The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a firm fixed-price purchase order valued at $49,748.73 to Novocure Inc. on September 4, 2025, for prosthesis delivery with an ultimate completion date of November 30, 2025. The award is not designated as a set-aside contract. Novocure Inc., a foreign-owned medical device manufacturer, will deliver products and services from its location in Portsmouth, New Hampshire. This purchase order is issued under Novocure's existing Federal Supply Schedule contract with the VA (FSS-65-II-A for Medical Equipment and Supplies), a $28.85 million multiple-award vehicle established on November 1, 2022, and extending through October 31, 2027.

Novocure specializes in innovative cancer therapy technologies, primarily the Optune system, which utilizes Tumor Treating Fields technology for treating solid tumor cancers including glioblastoma and mesothelioma. The company's FDA-approved medical devices and associated support services provide VA medical centers nationwide with non-invasive cancer treatment options for veteran patients. This delivery order continues Novocure's role as the sole provider of these specialized therapies under the established schedule contract, with no subcontractors involved in contract performance.